Fraiser Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 3.91 M
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 3.00 M
- Revenue Growth -30.08%
- Profit Growth 63.09%
- Ebitda -8.26%
- Net Worth -1.03%
- Total Assets 7.79%
About Fraiser Pharma Chem
Fraiser Pharma Chem Limited (FPCL) is a Public Limited Indian Non-Government Company incorporated in India on 19 February 2001 and has a history of 23 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Fraiser Pharma Chem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.91 M.
The company currently has active open charges totaling ₹3.00 M.
Gazala Khan, Mamta Thakur, and Dharmendranath Thakur serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231MH2001PLC130917
-
Company No.
130917
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Feb 2001
-
Date of AGM
05 Oct 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Fraiser Pharma Chem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendranath Thakur
|
Managing Director | 19-Feb-2001 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Gazala Khan
|
Director | 20-Nov-2012 | Current |
|
Mamta Thakur
|
Director | 20-Nov-2012 | Current |
Financial Performance of Fraiser Pharma Chem.
Fraiser Pharma Chem Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 30.08% decrease. The company also saw a substantial improvement in profitability, with a 63.09% increase in profit. The company's net worth dipped by a decrease of 1.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fraiser Pharma Chem?
In 2017, Fraiser Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Trimbakeshwar Pharma Private LimitedMamta Thakur and Dharmendranath Thakur are mutual person
-
Gopi Estate And Infra Private Limited
Mamta Thakur and Dharmendranath Thakur are mutual person
-
Gopi Hospitality Limited
Mamta Thakur and Dharmendranath Thakur are mutual person
-
Gopi Homenium Private Limited
Dharmendranath Thakur is a mutual person
-
Sai Krishna Hari Warkari Bhakt Niwas Foundation
Dharmendranath Thakur is a mutual person
Charges (Loans)
₹0.30 Cr
₹0
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Aug 2007 | Vijaya Bank | ₹2.50 M | Open |
| 31 Dec 2005 | Vijaya Bank | ₹0.50 M | Open |
How Many Employees Work at Fraiser Pharma Chem?
Unlock and access historical data on people associated with Fraiser Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fraiser Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fraiser Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
